3 news items
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
LGND
8 Apr 24
will depend on a number of factors including coverage and reimbursement levels from governmental authorities and health insurers as well as market
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
LGND
3 Apr 24
including coverage and reimbursement levels from governmental authorities and health insurers as well as market acceptance by healthcare providers
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
LGND
22 Feb 24
and reimbursement levels from governmental authorities and health insurers as well as market acceptance by healthcare providers; the market size for Fycoma may
- Prev
- 1
- Next